Velarion Records
Free. Unsubscribe any time.

Oric Pharmaceuticals, Inc. (ORIC)

Oric Pharmaceuticals, Inc. filed 13 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 19 transactions and 466,800 shares. None carries the SEC's AFF10B5ONE flag; all 13 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Oric Pharmaceuticals, Inc. 19

Adoption dates in Oric Pharmaceuticals, Inc. 4

Results prints in Oric Pharmaceuticals, Inc. 7

Trades before a print in Oric Pharmaceuticals, Inc. 0

Interval to Oric Pharmaceuticals, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Oric Pharmaceuticals, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 30, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

Oric Pharmaceuticals, Inc.’s insider trading plan record — 13 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001796280.